Quality of life in patients with metastatic triple-negative breast cancer on ADC: a qualitative, participatory study

SaciGoVie is a qualitative, participatory study aimed at better understanding the quality of life and experiences of patients with triple-negative metastatic breast cancer treated with Sacituzumab-Govitécan. Using semi-structured interviews conducted at different stages of treatment, the study explores the impact of treatment on physical, psychological and social dimensions, as well as the difficulties prioritized by the patients themselves. The aim is to better identify their needs in terms of supportive care and improve clinical management, while contributing to the development of assessment tools better adapted to this population.

If you identify patients potentially concerned and interested, please do not hesitate to talk to them or to contact the collective to arrange a remote interview.